Skip to main content
. 2019 Apr 23;17(6):4715–4722. doi: 10.3892/etm.2019.7521

Figure 3.

Figure 3.

Silencing of DLX6-AS1 inhibited gastric cancer cell migration and invasion. (A) BGC823 and (B) AGS cells were transfected with DLX6-AS1 siRNA or NC siRNA and a wound healing assay was performed to assess cell migration. A transwell assay was used to examine (C) BGC823 and (D) AGS cell invasion. **P<0.01 vs. siNC. DLX6-AS1, distal-less homeobox 6 antisense 1; siRNA, small interfering RNA; NC, negative control.